欧盟慢性鼻窦炎袖珍指南。
The EUFOREA pocket guide for chronic rhinosinusitis.
作者信息
Hellings P W, Fokkens W J, Orlandi R, Adriaensen G F, Alobid I, Baroody F M, Bjermer L, Senior B A, Cervin A, Cohen N A, Constantinidis J, De Corso E, Desrosiers M, Diamant Z, Douglas R G, Gane S, Gevaert P, Han J K, Harvey R J, Hopkins C, Kern R C, Landis B N, Lee J T, Lee S E, Leunig A, Lund V J, Bernal-Sprekelsen M, Mullol J, Philpott C, Prokopakis E, Reitsma S, Ryan D, Salmi S, Scadding G, Schlosser R J, Steinsvik A, Tomazic P V, Van Staeyen E, Van Zele T, Vanderveken O, Viskens A-S, Conti D, Wagenmann M
机构信息
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Allergy and Clinical Immunology Research Group, Leuven, Belgium; University Hospitals Leuven, Department of Otorhinolaryngology, Leuven, Belgium; University Hospital Ghent, Department of Otorhinolaryngology, Laboratory of Upper Airways Research, Ghent, Belgium; Department of otorhinolaryngology and head/neck surgery, Amsterdam University Medical Centres, location AMC, University of Amsterdam, Amsterdam, The Nethe.
Department of otorhinolaryngology and head/neck surgery, Amsterdam University Medical Centres, location AMC, University of Amsterdam, Amsterdam, The Netherland.
出版信息
Rhinology. 2023 Feb 1;61(1):85-89. doi: 10.4193/Rhin22.344.
Chronic rhinosinusitis (CRS) is known to affect around 5 % of the total population, with major impact on the quality of life of those severely affected (1). Despite a substantial burden on individuals, society and health economies, CRS often remains underdiagnosed, under-estimated and under-treated (2). International guidelines like the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) (3) and the International Consensus statement on Allergy and Rhinology: Rhinosinusitis 2021 (ICAR) (4) offer physicians insight into the recommended treatment options for CRS, with an overview of effective strategies and guidance of diagnosis and care throughout the disease journey of CRS.
已知慢性鼻-鼻窦炎（CRS）影响着约5%的总人口，对重症患者的生活质量有重大影响（1）。尽管CRS给个人、社会和医疗卫生经济带来了沉重负担，但它常常仍未得到充分诊断、评估和治疗（2）。诸如《欧洲鼻窦炎和鼻息肉立场文件》（EPOS）（3）以及《变应性鼻炎和鼻科学国际共识声明：2021年鼻窦炎》（ICAR）（4）等国际指南，为医生提供了CRS推荐治疗方案的见解，概述了有效策略，并在CRS的整个病程中提供诊断和护理指导。
Zotero 插件